Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2025-12-27 @ 3:42 AM
Study NCT ID:
NCT05633160
Status:
TERMINATED
Last Update Posted:
2025-08-29
First Post:
2022-11-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT)
Sponsor:
Clarity Pharmaceuticals Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-15
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-04-23
Completion Date Type:
ACTUAL
First Submit Date:
2022-11-21
First Submit QC Date:
None
Study First Post Date:
2022-12-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-24
Last Update Post Date:
2025-08-29
Last Update Post Date Type:
ESTIMATED